|
|
CONTENTS
| RESOURCES
& INFORMATION |
THE
STAFF OF THE VASCULAR DIAGNOSITC LABORATORY:
Jeffrey W.
Olin, D.O., R.V.T., Co-Director
Michael R. Jaff, D.O., R.V.T, Co-Director
Julianna Czum, M.D.
Peter Smith, M.D.
Stan Ort, R.V.T. Technical Director
Susan Gustavson, R.V.T., Director of Education, Research
and Quality Control
AJ Bomareddy, R.V.T.
Kathleen Jacobson
Danielle Dippel, R.V.T., R.D.M.S.
Dorothy Power, R.V.T.
|
CONTENTS
| RESOURCES
& INFORMATION |
INTRODUCTION
The
inaugural issue of the Heart and Vascular Institute (HVI) quarterly
ewsletter is dedicated to the Vascular Laboratory. Future issues
will highlight other imaging and treatment modalities, such as Electron
Beam Tomography (EBT) Ultrafast Heart Scan, MRI, Angiography
and Enhanced External Counterpulsation (EECP). Regular features
of this newsletter will include HVI News/Updates; the Heart and
Vascular Research Institute activities and clinical trials updates;
and publications and presentations by HVI staff. We welcome your
comments and suggestions for topics to include for future issues.
A wide variety of non-invasive vascular studies are offered at HVI.
The goal of the vascular laboratory is to provide excellent service
to our patients and referring physicians along with complete and
accurate test reports. We have already initiated a quality control
program, CME credits for all involved in the vascular lab and have
taken the early steps toward accredita-tion by the Intersocietal
Commission on the Accreditation of Vascular Laboratories (ICAVL).
In this edition of the Newsletter, a brief description of several
of the Vascular Lab studies currently available (with CPT codes)
and a number of appropriate indications (with ICD-9 codes) are included.
To facilitate patient scheduling and billing, please refer to these
codes when ordering Vascular Lab examinations.
|
CONTENTS
| RESOURCES
& INFORMATION |
DUPLEX
ULTRASOUND
Duplex ultrasound
studies combine the anatomic and morphologic information obtained
with gray-scale imaging (B-mode) along with hemo-dynamic data (spectral
and color Doppler), such as blood flow velocity and direction. The
quantitative data can then be utilized for other calculations that
enhance interpretation of the study results.
|
CONTENTS
| RESOURCES
& INFORMATION |
Carotid
Duplex Ultrasound
[CPT 93880 Bilateral, 93882 Unilateral]
The most frequently
performed study in the Vascular Lab, the carotid duplex ultrasound
is a non-invasive means of evaluating not only the common, external,
and internal carotid arteries, but also the vertebral and subclavian
arteries. Typical study indications include: carotid bruit [ICD-9
785.9], TIA [435.9], and the periodic surveillance of known carotid
disease [433.1-433.3].
B-mode imaging
is performed to identify and characterize atherosclerotic plaque.
Plaque can be characterized as one of three types on the ultrasound
report: homogeneous, heterogeneous, or calcified.
Homogeneous
plaque consists of calcium-free atheroma. The absence of any detectable
calcification results in a hypoechoic (few echoes; dark) appearance
on gray-scale imaging, rendering this form of plaque essentially
indistinguishable from the normally anechoic (echo-free and dark)
vessel lumen. On color Doppler images, however, areas with homo-geneous
plaque demonstrate no flow-related color.
Heterogeneous
plaque, as its name implies, has a corresponding intermediate echotexture
compared to homogeneous and calcified forms. This term can also
be used when areas of both homogeneous and calcified plaque can
be identified in the vessel segment. This indicates the presence
of some calcification, but not to the degree where the ultrasound
beam can no longer penetrate the plaque producing what is known
as acoustic shadowing.
Calcified plaque
appears uniformly echogenic (bright) on B-mode images, often with
posterior acoustic shadowing. Shadowing potentially limits the evaluation
of an affected vascular segment because sound waves are unable to
penetrate that area. If a velocity measurement cannot be obtained
with ultrasound in an area of stenosis, this can potentially underestimate
the degree of the stenosis. This is most important in distinguishing
between moderate (60-79%) and severe (80-99%) degrees of stenosis,
which have differing natural histories and are managed differently.
Another scenario
that presents a challenge to interpretation is the velocity elevation
contralateral to a carotid occlusion. This may lead to an overestimation
of the degree of stenosis or the false diagnosis of stenosis, in
its absence, on the ipsilateral side.
The Vascular
Lab uses a modification of the Strandness classification scheme
for assigning the degree of internal carotid arterial stenosis (Table
1).2, 3 Velocity and spectral criteria are utilized to
establish a range of percent diameter stenosis for the internal
carotid arteries.

No criteria
have been validated for the quantitation (percent stenosis) of common
carotid or external carotid disease severity. Instead, vascular
disease in these locations is described as mild, moderate, or severe,
based on subjective assessment of the plaque burden and peak systolic
velocity. Duplex ultrasound of the carotid artery has become so
accurate that most vascular surgeons are now performing a carotid
endarterectomy on the basis of ultrasound alone. Since carotid angiography
accounted for approximately 50% of the strokes in the Asymptomatic
Carotid Atherosclerosis Study (ACAS), it should be reserved for
situations where the carotid ultrasound is not clear, or technical
limitations preclude an accurate examination. Most patients who
have symptomatic carotid disease, however, should undergo angiography
prior to percutaneous or surgical intervention.
In general,
recommendations for follow-up are not included in the official report
because any such recommendations only apply to asymptomatic patients.
In addition, there are no rules that apply to every patient and
clinical decision making is necessary for each individual case.
However we have prepared general guidelines that are available to
all referring physicians (Table 2).

References:
1. Zwibel WJ. Doppler Evaluation of Carotid Stenosis. In Introduction
to Vascular Ultrasonography. W.B. Saunders. 1992; 9:123-132.
2. Neumyer M, et al. Validation of pre-screening with duplex scanning.
J. Vasc. Technology. 1987; 11:30-32.
3. Strandness DE and Taylor UW. Carotid artery duplex scanning.
Clin. Ultrasound. 1987; 15:625-644.
Renal
Artery Duplex Ultrasound
[CPT 93975 "RADUS"]
Since its introduction
into the Vascular Lab repertoire, the volume of this study has increased
enormously. This technically demanding study can identify hemodynamically
significant (60-99%) renal arterial stenoses.1, 2 The indications
for this study are: hypertension not adequately controlled despite
a good antihypertensive regimen [ICD-9 401.1], unexplained azotemia
[539.9], a small or atrophic kidney, or recurrent congestive heart
failure or flash pulmonary edema not explained by ischemic heart
disease.
Unlike the
carotid ultrasound study, which relies heavily on gray-scale imaging
for plaque characterization along with color Doppler and spectral
information, the renal arterial study relies almost entirely on
the Doppler spectral waveform and turbulence demonstrated on color
Doppler. The entire length of each renal artery (include accessory
arteries, when present) is evaluated via two approaches: transabdominal
(with the patient in the supine position) and through the flank
(with
the patient in the opposite decubitus position). The presence of
intestinal gas may severely limit study quality. Therefore all patients
should fast (including liquids) for 12 hours prior to a renal artery
duplex examination.
The abdominal
aortic and renal arterial peak systolic velocities are used to calculate
the renal-aortic ratio (RAR), a value used in conjunction with the
absolute renal arterial peak systolic velocity to determine the
severity of stenosis.
Intrarenal
arterial flow velocity is also documented. The peak-systolic (PSV)
and end-diastolic velocities (EDV) are used to calculate the resistive
index (RI) by the formula: (PSV-EDV)/PSV. The RI value reflects
the degree of resistance to flow within the kidneys. High RI values
(close to 1.0) are consistent with intra-renal resistance due to
parenchymal abnormalities such as nephrosclerosis and other renal
pathology.
B-mode imaging
is used primarily to obtain the length of each kidney. Although
the ultrasound parameters are optimized for renal vascular rather
than renal parenchymal evaluation, gray-scale image findings, such
as cysts, masses, cortical thinning, and hydronephrosis can be detected.
However, findings of uncertain significance, such as a complex renal
mass, cannot be fully and properly analyzed with this technique.
In such circumstances, further evaluation is advised.
The mesenteric
arterial velocities are also obtained. The celiac axis and superior
mesenteric artery (SMA) are routinely identified in all studies.
The inferior mesenteric artery (IMA) is seen less frequently because
it is often occluded in patients with abdominal aortic aneurysm
and in the elderly.
References:
1. Olin JW. Role of duplex ultrasonography in screening for significant
renal artery disease. Urol. Clin. of No. Amer. 1994; 21:215-226.
2. Olin JW, et al. The utility of duplex ultrasound scanning of
the renal arteries for diagnosing significant renal artery stenosis.
Ann. Int. Med. 1995; 122:833-838.
Mesenteric
Duplex Ultrasound
[CPT 93976 RADUS-limited]
Although most
mesenteric arterial stenoses are asymptomatic due to the extensive
collateral network of the gastrointestinal tract, post-prandial
abdominal pain and weight loss may indicate the presence of bona-fide
chronic intestinal ischemia. This condition is usually associated
with at least two of the three mesenteric vessels having a significant
stenosis (70-99%) or occlusion. An abdominal bruit [ICD-9 789.5]
may be present.
In young adults,
especially females with an aesthenic body habitus, the celiac peak
systolic velocity may vary widely during the respiratory cycle due
to dynamic compression of the proximal celiac axis by the median
arcuate ligament of the diaphragm (also know as celiac artery compression
syndrome). Unlike the atherosclerotic form of mesenteric arterial
disease, individuals with the median arcuate compression syndrome
often do not have symptoms and are not at increased risk for bowel
ischemia.
Although an
obvious abdominal aortic aneurysm (AAA) will be documented by the
technologist during both the renal arterial and the mesenteric arterial
duplex studies, these tests are not intended as AAA examinations
per se. The correct study to order for AAA detection is an abdominal
aortic ultrasound.
Abdominal
Aorta Duplex Ultrasound
[CPT 93978 Abdominal Duplex]
A palpable
pulsatile mass [ICD-9 789.30] is the most common indication for
this study request. In addition, approximately 20% of first degree
offspring of an individual who had an abdominal aortic aneurysm
will eventually have an AAA.
The technologist
systematically interrogates the entire length of the abdominal aorta
as well as the common iliac arteries for the presence of an enlargement.
Multiple diameter measurements in the AP, transverse and sagittal
views are obtained in the suprarenal, juxtarenal, and infrarenal
aortic segments. Aortic and common iliac velocity measurements and
waveforms are obtained using Doppler. The mesenteric and renal arteries
are not evaluated during this study (see above for appropriate studies).
Other
arterial duplex studies:
Not discussed
in this issue of the newsletter, we also routinely perform arterial
duplex of the lower extremities [CPT 93925 (unilateral) and 93926
(bilateral)] for indications such as graft surveillance and, in
the post-catheterization patient, in the assessment of pseudoaneurysm
and A-V fistula [ICD-9 447.0]. When appropriate, ultrasound-guided
thrombin injection can be performed at the time of pseudoaneurysm
diagnosis. Arterial duplex studies for the upper extremities [CPT
93930 (unilateral) and 93931 (bilateral)] and arterial mapping will
also be available.
Note: In addition
to the primary study indication, a second ICD-9 code [250.00 through
250.73] should be selected for any patient with diabetes. ("Diabetes"
cannot be coded as a primary indication for any Vascular Lab study.)
|
CONTENTS
| RESOURCES
& INFORMATION |
PVR
[CPT 93923 PVR, 93924 PVR with exercise, 93922 ABI]
The PVR (pulse-volume
recording) with segmental pressures is an excellent diagnostic tool
in patients suspected of having peripheral arterial disease (PAD).
The information that one can get from PVRs is:
- Confirm or rule
out (PVR with exercise) the presence of peripheral arterial disease.
- Determine the
level of vascular disease.
- Determine the
severity of vascular disease.
- Quantify functional
impairment (treadmill test)
- Predict the level
of amputation in those patients without other options.
- Provide objective
evidence of improvement or worsening after a percutaneous or surgical
intervention.
Blood pressure measurements
are first obtained from each upper extremity (brachial). (Discrepancy
between the arm pressures usually indicates sub-clavian or innominate
stenosis.) Blood pressure cuffs are then applied to the thigh, calf,
ankle, metatarsal region of the foot, and great toe. Pressure measurements
obtained at the thigh, calf, and ankle are compared with the upper
extremity (the higher of the two brachial measurements). At the
level of the ankle, this ratio is known as the ABI (ankle-brachial
index). Gradients (segmental pressure drops) along the extremity
help to localize the general level of arterial disease and provide
a clue to the vessel or vessels affected. In addition, the overall
severity of PAD in an affected limb is assessed at the level of
the ankle via the ABI (see Table 3).

Analysis of the waveform
morphology and relative amplitude is especially important in the
presence of arterial calcification, which can falsely elevate pressure
readings (resulting in false negative studies). In fact, calcification
can render the arteries "non-compressible", i.e. pressures registering
above the scale of the equipment (over 255 mmHg).
If the study is normal
at rest, an exercise study should be performed. The patient is asked
to walk on the treadmill at 2.5 mph and 12% grade in an attempt
to reproduce the patient's chief complaint (usually pain or discomfort
in the buttocks, hip, thigh, calf, etc.).
At the end of the treadmill
portion, the patient is quickly re-evaluated at the level of the
ankle bilaterally with both pressure measurements and waveform analysis.
A significant drop in pressure from the rest portion is consistent
with PAD. However, as only the ankle measurement is obtained, the
exact site of arterial narrowing in the corresponding lower extremity
cannot be determined.
PVR's can also be obtained
in the upper extremities in patients with arm claudication or ulcerations
on the fingers. In patients with symptoms suggestive of thoracic
outlet syndrome, a specific thoracic outlet study should be obtained.
|
CONTENTS
| RESOURCES
& INFORMATION |
Lower
Extremity Venous Duplex Ultrasound
[CPT 93970 Bilateral, 93971 Unilateral]
These studies are almost
always ordered to confirm or exclude the presence of a clinically
suspected deep venous thrombosis (DVT) in patients with lower extremity
pain [ICD-9 729.5] and/or swelling [729.81]. The lower extremity
venous tree is evaluated using Doppler maneuvers, B-mode imaging
to visualize thrombus and by using compression. Features of an acute
DVT ultrasonographically are:
- A dilated vein
segment.
- Inability to compress
the vein (cannot get the walls to coapt).
- May or may not
visualize thrombus in the acute stage since it is less echogenic
than subacute or chronic thrombus.
If the vein is not dilated,
or highly echogenic thrombus is visualized, the report may read
either "DVT, age indeterminate" or "remote DVT". In this situation,
clinical judgement will be necessary to determine how the patient
should be treated. Once a patient is started on anti-thrombotic
therapy, there is no need to repeat the duplex venous study unless
new symptoms occur.
A lower extremity duplex
study for acute DVT will be performed the same day it is ordered.
If you have difficulty obtaining this study, call one of us immediately.
We will also be performing venous insufficiency studies and upper
extremity duplex studies.
|
CONTENTS
| RESOURCES
& INFORMATION |
Accreditation
The Intersocietal Commission
for the Accreditation of Vascular Laboratories (ICAVL) is formed
by representatives from multiple organizations which include, among
others, the American College of Cardiology (ACC), the American Institute
of Ultrasound in Medicine (AIUM), the Society of Cardiovascular
and Interventional Radiology (SCVIR), the Society for Vascular Medicine
and Biology (SVMB), the Society for Vascular Surgery (SVS), and
the Society of Vascular Technology (SVT). Personnel, instrumentation,
components of study performance, reporting, correlation with other
imaging studies, quality assurance, and procedure volume are some
of the Vascular Lab features which are examined.
For
greater detail, a copy of the ICAVL's "Standards 2000" is available
at each Vascular Lab location.
|
CONTENTS
| RESOURCES
& INFORMATION |
The
Society of Vascular Medicine and Biology
Founded
in 1989, SVMB fosters the integration of vascular biological advances
into clinical practice and promotes an interactive collegial approach
for delivering the highest quality care to patients with vascular
disorders. The mission of the Society also includes the formation
of formal research and educational opportunities for doctors-in-training
as well as continuing medical education for practicing physicians.
If
you are interested in becoming a member or learning more about the
Society, please contact Dr. Jeffrey Olin, the Society's current
president, or visit the Society's website at www.svmb.org.
|
CONTENTS
| RESOURCES
& INFORMATION |
Appropriate
ICD-9 codes
|
BACK TO APPROPRIATE
ICD-9 CODES |
CONTENTS
| RESOURCES
& INFORMATION |

|
BACK TO APPROPRIATE
ICD-9 CODES |
CONTENTS
| RESOURCES
& INFORMATION |

|
BACK TO APPROPRIATE
ICD-9 CODES |
CONTENTS
| RESOURCES
& INFORMATION |

|
BACK TO APPROPRIATE
ICD-9 CODES |
CONTENTS
| RESOURCES
& INFORMATION |
HVI
Staff & Hours
The Heart & Vascular
Institute
111 Madison Avenue, Morristown, NJ 07960
Phone: 973-656-0555
Fax: 973-656-0174
Hours:
Monday - Friday:
7:30 AM- 5:30 PM
Staff:
Jeffrey
W. Olin, DO, FACC, FACP
Director, The Heart & Vascular Institute Co-Director, Vascular Diagnostic
Laboratory
Michael
R. Jaff, DO, FACP, FACC
Director, Vascular Medicine Program Co-Director, Vascular Diagnostic
Laboratory
Peter
L. Smith, MD, MACR
Director, Endovascular Services
Julianna
M. Czum, MD
Director, Vascular MR
James
F. London, MD
Director, Cardiac MR
Patricia
E. Houser, RN
Administrator
Ann
McKnight
Office Supervisor
Linda
Carricarte
Administrative Assistant
Maureen
Lowe, RT (AS, R, CT)
CT Technologist
John
Jacobacci, RT (R, MR)
MR Technologist
Christopher
Konkus, RT (R, MR)
MR Technologist
Ken
Brown, RT (R)
Angiography Technologist
Stan
Ort, RVT
Technical Director, Vascular Laboratory
Eileen
M. MacCallum, RN, APN, C
Nurse Practitioner
Marla
Lynne Bell, RN, APN, C
Nurse Practitioner
|
CONTENTS
| RESOURCES
& INFORMATION |
|